Efficacy and safety profile of vortioxetine as an add-on molecule in obsessive-compulsive disorder: a randomized double-blinded placebo-controlled superiority trial – a study protocol
The trial was registered with the Clinical Trials Registry - India (CTRI) (registration ID: CTRI/2023/12/060748) on December 26, 2023.
Authors
- Aparajita Guin (ORCID: https://orcid.org/0009-0000-5518-8352)
- Kamini Verma
- Kaushik Mukhopadhyay (ORCID: https://orcid.org/0000-0002-9928-9670)
- Prasenjit Mitra (ORCID: https://orcid.org/0000-0003-4826-1587)
- Sucharita Mandal
- Sukriti Mukherjee (ORCID: https://orcid.org/0009-0000-3550-5090)
- Bisweswar Ojha
- Rupal Sorkhel
Institutions
- All India Institute of Medical Sciences Raipur (IN)
- All India Institute of Medical Sciences Jodhpur (IN)
- All India Institute of Medical Sciences Bhopal (IN)
- All India Institute of Medical Sciences (IN)
- University of Kalyani (IN)
Publication Details
- Journal
- BMC Psychiatry
- Published
- 2025-11-24
- DOI
- https://doi.org/10.1186/s12888-025-07374-2
- Primary Topic
- Obsessive-Compulsive Spectrum Disorders
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Indian Council of Medical Research
- All-India Institute of Medical Sciences